Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 18, 2023
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
Soumit Roy Initiated (ACRV) at Strong Buy and Held Target at $26 on, Aug 18th, 2023
Soumit Roy of JonesTrading, Initiated "Acrivon Therapeutics, Inc." (ACRV) at Strong Buy and Held Target at $26 on, Aug 18th, 2023.
Soumit has made no other calls on ACRV in the last 4 months.
There are 3 other peers that have a rating on ACRV. Out of the 3 peers that are also analyzing ACRV, 0 agree with Soumit's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Soumit
- Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $20 on, Friday, August 11th, 2023
- Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $25 on, Friday, June 2nd, 2023
- Etzer Darout of "BMO Capital" Initiated at Buy and Held Target at $25 on, Monday, May 8th, 2023
